Sherene Loi

The University of Melbourne

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 25 papers. Top paper: “Pervasive chromosomal instability and karyotype order in tumour evolution”.

Pervasive chromosomal instability and karyotype order in tumour evolution

Nature(2020)10.1038/s41586-020-2698-6

N/A

7.1DataRank · unranked

405 citations

Emilia L. Lim, Marina Petković, Sergi Elizalde, Nicolai J. Birkbak, Gareth A. Wilson +50 more

Embracing cancer complexity: Hallmarks of systemic disease

Cell(2024)10.1016/j.cell.2024.02.009

N/A

6.5DataRank · unranked

498 citations

Elsa Bernard, Chris Abbosh, Fabrice Andre, Johan Auwerx, Allan Balmain +28 more

Geospatial immune variability illuminates differential evolution of lung adenocarcinoma

Nature Medicine(2020)10.1038/s41591-020-0900-x

N/A

5.8DataRank · unranked

290 citations

Shan E Ahmed Raza, Rachel Rosenthal, Mariam Jamal‐Hanjani, Selvaraju Veeriah, Ayse U. Akarca +18 more

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2021)10.1038/s41523-021-00346-1

N/A

4.9DataRank · unranked

281 citations

Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner +73 more

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2020)10.1038/s41523-020-0154-2

N/A

3.5DataRank · unranked

168 citations

Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon +95 more

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

Nature Communications(2020)10.1038/s41467-020-20138-8

N/A

2.3DataRank · unranked

93 citations

Bastien Nguyen, Guillermo Yoldi, Marina Ciscar, Alexandra Barranco, Enrique Hernández-Jiménez +29 more

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

Journal of Clinical Oncology(2022)10.1200/jco.22.01065

N/A

2.2DataRank · unranked

59 citations

Gini F. Fleming, István Láng, Eva Ciruelos, Hervé Bonnefoi, Meritxell Bellet +22 more

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

Annals of Oncology(2023)10.1016/j.annonc.2023.08.003

N/A

1.4DataRank · unranked

61 citations

L.D. Eli, Hans Wildiers, Sara A. Hurvitz, Ángel Guerrero‐Zotano, Nisha Unni +37 more

The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial

Cancer Discovery(2018)10.1158/2159-8290.cd-18-0264

N/A

0.977DataRank · unranked

675 citations

Rosalind J. Cutts, Yuan Liu, Sarah Hrebien, Xin Huang, Kerry Fenwick +8 more

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-0156-0

N/A

0.801DataRank · unranked

208 citations

Elvire Roblin, Rim S. Kim, Stefan Michiels, Brandon D. Gallas, Weijie Chen +95 more

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1796

N/A

0.680DataRank · unranked

24 citations

Meritxell Bellet, Nicholas C. Turner, Sherene Loi, Aditya Bardia, Valentina Boni +17 more

Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3685

N/A

0.617DataRank · unranked

60 citations

Mellissa J. Nixon, Paula I. González-Ericsson, Riley E. Bergman, Mark A. Pilkinton, Wyatt J. McDonnell +21 more

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials

Nature Communications(2023)10.1038/s41467-023-42635-2

N/A

0.434DataRank · unranked

17 citations

Aranzazu Fernández-Martínez, David Venet, Françoise Rothé, Katherine A. Hoadley, Joel S. Parker +17 more

Research autopsy programmes in oncology: shared experience from 14 centres across the world

The Journal of Pathology(2024)10.1002/path.6271

N/A

0.425DataRank · unranked

16 citations

Marion Maetens, Jody E. Hooper, Steffi Oesterreich, Adrian V. Lee, Lori Miller +41 more

Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502

npj Breast Cancer(2024)10.1038/s41523-024-00683-x

N/A

0.419DataRank · unranked

7 citations

Roberto Salgado, Oleksander Savenkov, Karla V. Ballman, Erica L. Mayer, Mark Jesus M. Magbanua +11 more

Association of tumor infiltrating lymphocyte quantity with survival in patients (pts) with metastatic breast cancer (MBC) receiving microtubule-targeting agents: Post hoc analysis CALGB 40502 (Alliance).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1010

N/A

0.203DataRank · unranked

2 citations

Roberto Salgado, Oleksandr Savenkov, Karla V. Ballman, Mark Jesus M. Magbanua, Sherene Loi +11 more

Antigen reactivity defines tissue-resident memory and exhausted T cells in tumours

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.23.666465

N/A

0.165DataRank · unranked

2 citations

Jan Schröder, Luke C. Gandolfo, Maleika Osman, Elanor N. Wainwright, Enid Y.N. Lam +38 more

Data from Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

(2024)10.1158/1078-0432.c.7077719

N/A

0DataRank · unranked

0 citations

Meritxell Bellet, Nicholas C. Turner, Sherene Loi, Aditya Bardia, Valentina Boni +17 more

Data from Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

(2024)10.1158/1078-0432.c.7077719.v1

N/A

0DataRank · unranked

0 citations

Meritxell Bellet, Nicholas C. Turner, Sherene Loi, Aditya Bardia, Valentina Boni +17 more

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials

UNC Libraries(2024)10.17615/6kd2-qh45

N/A

0DataRank · unranked

0 citations

A Fernandez-Martinez, Françoise Rothé, EP Winer, David Venet, I.E. Krop +17 more

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.40931

N/A

0DataRank · unranked

2 citations

Yue Ren, Yi Zhang, Natalia Siuliukina, Catherine A. Schnabel, Roswitha Kammler +27 more

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00

iScience(2025)10.1016/j.isci.2025.112964

N/A

0DataRank · unranked

0 citations

Takashi Semba, Mattia Rediti, Daniel J. McGrail, Xuemei Xie, Xiaoping Wang +13 more

Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer

Breast Cancer Research(2021)10.1186/s13058-021-01395-x

N/A

0DataRank · unranked

13 citations

Rhonda Arthur, Yihong Wang, Sheila Weinmann, Mindy Ginsberg, Sherene Loi +2 more

Immunotherapy Approaches for Breast Cancer Patients in 2023

Cold Spring Harbor Perspectives in Medicine(2023)10.1101/cshperspect.a041332

N/A

0DataRank · unranked

65 citations

Sherene Loi, Leisha A. Emens

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women

Annals of Oncology(2023)10.1016/j.annonc.2023.01.009

N/A

0DataRank · unranked

48 citations

Giuseppe Viale, Serena Nik‐Zainal, Peter Savas, Roswitha Kammler, Patrizia Dell’Orto +33 more